Tech Transfer eNews Blog

U of Michigan start-up advances online platform that identifies hereditary cancer risk


By Jesse Schwartz
Published: July 10th, 2019

A University of Michigan (U-M) start-up has developed an online platform that helps identify patients at risk for hereditary cancers without them having to visit a doctor.

Developed by U-M researchers David Keren, Sofia Merajver, Lee Schroeder, Lynn McCain and Kara Milliron, the technology behind InheRET Inc. analyzes patients’ familial health history and health pedigree, then sends reports to the patients indicating whether or not they should see a genetics specialist. The reports can be saved and updated at any time, and may be kept private or shared with health care providers and family members.

A vast majority of Americans at increased risk for hereditary cancers remain unaware of the risk until they are diagnosed with cancer. Individuals at risk for colon, rectal, breast, ovarian and other common cancers could reduce their risk by as much as 95% if identified prior to cancer onset.

InheRET’s technology has been tested on nearly 500 patients at Michigan Medicine, the medical center at U-M where the program was initially developed. It is now available to the general public and to health care centers via subscription.

“It’s amazing the progress that the InheRET team has made since launching the company this past December,” says Bryce Pilz, director of licensing at U-M Tech Transfer. “In just six month’s time, they’ve launched their hereditary risk assessment tool and are making a positive difference in the lives of people, and that’s incredibly gratifying to see.”

Source: Michigan News

Posted under: Tech Transfer e-News

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment